Preclinical WebsiteClinical Website
Table of Contents

Table of Contents

Abstract
01. Presentation Overview
Presentation
01. Introduction02. Regional Volumes Analysis Methods03. Cortical Thickness Analysis Methods04. TDP-43 Model05. TDP-43 Model MR Images06. TDP-43 Model MRI Analysis07. Alpha-Synuclein Model08. Synuclein Model MR Images09. Synuclein Model MRI Analysis10. Summary

α-Synuclein preformed fibril (PFF) inoculation into a M83+/- transgenic mouse model of Parkinson's disease:

  • Transgenic mice overexpressing α-synuclein with an A53T mutation
  • Injection of recombinant, human PFFs into the Anterior Olfactory Nucleus (AON)
  • Seeding and spreading of pathology to connected brain regions
  • Progressive neurodegeneration (including MRI brain atrophy and elevated NfL in plasma & CSF)
  • Strong microgliosis and astrogliosis in regions of ∝-synuclein pathology
α-Synuclein (p-Syn) pathology seen in the piriform cortex of M83+/- PFF mice after unilateral stereotaxic injection of α-synuclein PFFs into the AON.
Microgliosis (Iba-1) seen in the piriform cortex of M83+/- PFF mice after unilateral stereotaxic injection of α-synuclein PFFs into the AON.
Neurodegeneration (NeuN) seen in the piriform cortex of M83+/- PFF mice after unilateral stereotaxic injection of α-synuclein PFFs into the AON.
Astrogliosis (GFAP) seen in the piriform cortex of M83+/- PFF mice after unilateral stereotaxic injection of α-synuclein PFFs into the AON.

α-Synuclein (p-Syn) pathology [top left], microgliosis (Iba-1) [top right], neurodegeneration (NeuN) [bottom left], and astrogliosis (GFAP) [bottom right] seen in the piriform cortex of M83+/- PFF mice after unilateral stereotaxic injection of α-synuclein PFFs into the AON.

Please note that we provide a link to all of our Parkinson's disease and other CNS disease models on the last page of this presentation.

--:--

We routinely acquire anatomical MRI scans and perform brain atrophy analysis as part of therapeutic efficacy studies using our alpha-synuclein preformed fibril seeding and spreading model of Parkinson's disease. 

For model generation, we breed and age hemizygous M83 mice to 8 to 12 weeks-of-age. We then perform stereotaxic inoculation of sonicated preformed fibrils into the anterior olfactory nucleus (AON). This model shows neurodegeneration in a spatiotemporal pattern that follows the synuclein pathology.

For this study, we analyzed MRI data from PBS control and PFF injected mice at different time points post-inoculation.

We use necessary cookies to make our site work. We also use other cookies to help us make improvements by measuring how you use the site or for marketing purposes. You have the choice to accept or reject them all. For more detailed information about the cookies we use, see our Privacy Notice.